Search Results for: PPMI

PPMI Study Update: Early Signs and Some Potential Markers

Monday, 30 September 2019

The landmark Parkinson’s Progression Markers Initiative (PPMI) study aims to better define and measure Parkinson’s disease so scientists can find new ways to treat it. Now following nearly 1,400 participants at 33 clinical sites around the world, PPMI collects data…

PPMI Study Reaches Important Milestone

Friday, 21 December 2018

The Parkinson’s Progression Markers Initiative (PPMI) has reached an important milestone: the study completed enrollment. We have now met the ambitious goal we set back in 2010 of enrolling 1,400 participants, including 600 with rare genetic mutations. PPMI is The…

Parkinson's Biomarker

PPMI Data Shows Brain Changes Linked to Parkinson’s Progression

Monday, 14 August 2017

Two recent papers point to potential Parkinson’s biomarkers after analysis of data from The Michael J. Fox Foundation’s (MJFF) Parkinson’s Progression Markers Initiative (PPMI). PPMI is a landmark study following more than 1,500 volunteers at 33 clinical sites around the…

PPMI Shows Protein Levels Lower in Spinal Fluid of People with Parkinson’s

Wednesday, 25 June 2014

Keen to find out more about the latest research findings from the PPMI Project? Principal investigator of the PPMI, Ken Marek, MD, presented the latest findings from the landmark biomarkers study — sponsored by The Michael J. Fox Foundation — at the 18th International Congress of Parkinson’s Disease and Movement Disorders in Stockholm, Sweden earlier this month. Continue reading

More Alpha-Synuclein in Spinal Fluid Linked to Faster Cognitive Decline

Important PPMI Results Highlighted in USA Today

Tuesday, 27 August 2013

The first major study results from the Parkinson’s Progression Markers Initiative (PPMI) are highlighted in today’s edition of USA Today. The study, which was published in the journal JAMA Neurology, studied the cerebrospinal fluid of people with Parkinson’s disease (PD)…

PPMI Data used to publish first paper

First Paper Featuring PPMI Data Is Published

Thursday, 10 January 2013

Today, an important milestone for the Parkinson’s Progression Markers Initiative (PPMI), as, for the first time, researchers have published a scientifically-reviewed paper using data culled from the study. The paper appears in Neurology, the medical journal of the American Academy of Neurology, and…

PPMI Study – First results coming in!

Monday, 19 December 2011

The Parkinson’s Progression Markers Initiative (PPMI), the Foundation’s landmark clinical study to find biomarkers of Parkinson’s disease (PD), is now reporting its first results. The study has been amassing a large database of clinical and neuroimaging data, which has been…

PPMI Study

Sunday, 14 August 2011

About PPMI The Parkinson’s Progression Markers Initiative (PPMI) is an observational research study to identify biomarkers of Parkinson’s disease (PD) progression. A biomarker is a substance or characteristic in our bodies that is associated with the presence of disease, or…

Podcast – Latest in Parkinson’s Research

Monday, 6 May 2019

Earlier this month three members of The Michael J. Fox Foundation staff sat with Contributing Editor Dave Iverson to discuss the latest findings and research to better define, measure and treat Parkinson’s disease. Listen to the Podcast Download the Audio…

Michael J. Fox Foundation Monthly Webinar

Parkinson’s Research Year in Review and Look Ahead

Monday, 26 November 2018

Parkinson’s research continues to advance at a rapid pace. Led by moderator Soania Mathur, MD, co-chair of The Michael J. Fox Foundation’s Patient Council, panelists Andrew Siderowf, MD, director, Parkinson’s Disease and Movement Disorders Center and Todd Sherer, PhD, MJFF…